Dr. Rick Munschauer has extensive academic and industry experience in neurology designing and conducting a host of Phase I-IV clinical trials in multiple neurological therapeutic areas.

Before joining Emalex, he served as vice president of global product development, neurosciences, at PPD, CMO of Marathon and MedDay Pharma, and global head of medical affairs at Biogen.

Prior to his work in the industry, Dr. Munschauer was Smith Professor and Chair, Neurology, University of NY at Buffalo. He has also held multiple professional society leadership roles including the National Board of Directors of the National MS Society, Consortium of MS Centers, and the American Stroke Association.

Dr. Munschauer received bachelor’s degrees in Electrical and Mechanical Engineering from Duke University and a master’s degree in Mechanical Engineering from MIT. He graduated from McGill University Faculty of Medicine and completed residencies in internal medicine and neurology at Johns Hopkins. Dr. Munschauer also completed fellowships in intensive care at the National Hospital for Nervous Disease, London and neuroimmunology and neuroimaging at the University of NY at Buffalo. He is board certified in neurology, internal medicine and critical care.